Strictureplasty has recently been advocated in the treatment of obstru
ctive strictures of the small bowel in patients with Crohn's disease.
In this group study, results for 69 patients with Crohn's disease who
underwent strictureplasty were analyzed by sending questionnaires to 1
3 institutions belonging to the Research Committee of Inflammatory Bow
el Disease of the Japanese Ministry of Health and Welfare. No mortalit
y and anastomotic leakage were observed. Strictureplasties of both the
Heineke-Mikulicz and Finney varieties were considered to be safe proc
edures, even though the sutures had to be applied at the slightly infl
ammed site. The median follow up was 37 months (range, 0-133 months),
and 12 patients needed reoperation. The cumulative 3-year operation-fr
ee rate was 92.5% and the 5-year rate was 70.3%. The site of the lesio
n, the strictureplasty procedure, and previous history of small bowel
resection did not significantly influence the operation-free intervals
. The cumulative 5-year operation-free rate of the group treated with
home elemental enteral nutrition (83.3%) was better than that of the n
on-treated group (65.3%). Strictureplasty was found to be a safe and e
ffective surgical procedure for high-risk patients with Crohn's diseas
e in whom an appropriate length of bowel should be saved.